Case Study: CareMetx Omnichannel Program Drives Initiation and Persistence for a Self-Injectable Rheumatology Biologic

Self-injectable drugs help patients manage chronic conditions from the convenience of home, yet they’re more complicated to administer than oral drugs, creating barriers for patients to initiate and stay on therapy. Patients with a chronic inflammatory disease can encounter obstacles throughout the care journey—from poor health and low literacy before the diagnosis, to anxiety about the injection process once they receive a RX, to lack of motivation and side effects concerns throughout their therapy.

 

Download the case study PDF to read more